| 國立臺灣大學 |
1989 |
Second-harmonic generation on simple metal surfaces: A quantum-mechanical point of view
|
Hu, C. D. |
| 臺大學術典藏 |
2018-09-10T07:35:02Z |
Second-harmonic generation on simple metal surfaces: A quantum-mechanical point of view
|
CHONG-DER HU; Hu, C.D.; Hu, C.D. |
| 國立政治大學 |
2009.12 |
Second-harmonic generation with magnetic-field controllability
|
郭光宇; Ju, Sheng ; Cai, Tian-Yi ; Wei, Chi-I ; Guo, Guang-Yu |
| 國立臺灣大學 |
2009 |
Second-harmonic generation with magnetic-field controllability
|
Ju, S.; Cai, T. Y.; Wei, C. I.; Guo, G. Y. |
| 臺大學術典藏 |
2018-09-10T07:35:00Z |
Second-harmonic generation with magnetic-field controllability
|
Ju, S.;Cai, T.-Y.;Wei, C.-I.;Guo, G.-Y.; Ju, S.; Cai, T.-Y.; Wei, C.-I.; Guo, G.-Y.; GUANG-YU GUO |
| 國立臺灣大學 |
2003 |
Second-harmonic green generation from two-dimensional (2) nonlinear photonic crystal with orthorhombic lattice structure
|
Peng, L.H.; Hsu, C.-C.; Shih, Y.-C. |
| 臺大學術典藏 |
2018-09-10T04:35:54Z |
Second-harmonic green generation from two-dimensional chi((2)) nonlinear photonic crystal with orthorhombic lattice structure
|
L.-H. Peng,; C.-C. Hsu,; Y.-J. Shih,; LUNG-HAN PENG |
| 國立臺灣大學 |
2004-01 |
Second-language learning
|
Chang, C. M |
| 佛光大學 |
2004-01-01 |
Second-language learning.
|
鄭昭明 |
| 國立政治大學 |
2007-08 |
Second-Language Reading Behavior among Taiwanese University Students: A Mentalistic Investigation of Strategies
|
Hull, Jonathan C.; Hou, Yi-Chun Sami |
| 臺大學術典藏 |
2021-08-31T06:29:16Z |
Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial
|
Kelley R.K.; Ryoo B.-Y.; Merle P.; Park J.-W.; Bolondi L.; Chan S.L.; Lim H.Y.; Baron A.D.; Parnis F.; Knox J.; Cattan S.; Yau T.; Lougheed J.C.; Milwee S.; El-Khoueiry A.B.; ANN-LII CHENG; Meyer T.; Abou-Alfa G.K. |
| 國立臺灣大學 |
2013 |
Second-line pemetrexed treatment in Taiwanese patients with advanced nonsmall cell lung cancer: An open-label single-arm study
|
Chang, Gee-Chen; Tsai, Chun-Ming; Hsia, Te-Chun; Yang, Chih-Hsin; Abdulnabi, Radhi; Blair, Julie M.; Linn, Carlos; 楊志新 |
| 臺大學術典藏 |
2020-05-26T09:27:04Z |
Second-line pemetrexed treatment in Taiwanese patients with advanced nonsmall cell lung cancer: An open-label single-arm study
|
Chang G.-C;Tsai C.-M;Hsia T.-C;Chih-Hsin Yang;Abdulnabi R;Blair J.M;Linn C.; Chang G.-C; Tsai C.-M; Hsia T.-C; CHIH-HSIN YANG; Abdulnabi R; Blair J.M; Linn C. |
| 中國醫藥大學 |
2013-09 |
Second-line pemetrexed treatment in Taiwanese patients with advanced nonsmall cell lung cancer: an open-label single-arm study.
|
(Chang GC);(Tsai CM);夏德椿(Te-Chun Hsia);(Yang CH);(Abdulnabi R,);(Blair JM);(Linn C)* |
| 國立成功大學 |
2016-11-15 |
Second-line ramucirumab therapy for advanced hepatocellular carcinoma (REACH): an East Asian and non-East Asian subgroup analysis
|
Park, Joon Oh; Ryoo, Baek-Yeol; Yen, Chia-Jui; Kudo, Masatoshi; Yang, Ling; Abada, Paolo B.; Cheng, Rebecca; Orlando, Mauro; Zhu, Andrew X.; Okusaka, Takuji |
| 臺大學術典藏 |
2020-05-26T09:26:23Z |
Second-line treatment of EGFR T790M-negative non-small cell lung cancer patients
|
Liao B.-C;Griesing S;Chih-Hsin Yang; Liao B.-C; Griesing S; CHIH-HSIN YANG |
| 臺大學術典藏 |
2021-08-20T08:00:39Z |
Second-line treatment of EGFR T790M-negative non-small cell lung cancer patients
|
BIN-CHI LIAO; Griesing S.; Yang J.C.-H. |
| 國立臺灣大學 |
2010 |
Second-Line Treatments after First-Line Gefitinib Therapy in Advanced Nonsmall Cell Lung Cancer
|
巫震宇; 施金元; 楊志新; 陳冠宇; 何肇基; 余忠仁; 楊泮池; WU, JENN-YU; SHIH, JIN-YUAN; YANG, CHIH-HSIN; CHEN, KUAN-YU; HO, CHAO-CHI; YU, CHONG-JEN; YANG, PAN-CHYR |
| 臺大學術典藏 |
2018-09-10T08:02:58Z |
Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer
|
Wu, J.-Y. and Shih, J.-Y. and Yang, C.-H. and Chen, K.-Y. and Ho, C.-C. and Yu, C.-J. and Yang, P.-C.; Chong-Jen Yu; CHAO-CHI HO; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-05-26T09:27:18Z |
Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer
|
Wu J.-Y;Shih J.-Y;Chih-Hsin Yang;Chen K.-Y;Ho C.-C;Yu C.-J;Yang P.-C.; Wu J.-Y; Shih J.-Y; CHIH-HSIN YANG; Chen K.-Y; Ho C.-C; Yu C.-J; Yang P.-C. |
| 臺大學術典藏 |
2020-07-21T06:46:33Z |
Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer
|
Wu J.-Y.; Shih J.-Y.; Yang C.-H.; Chen K.-Y.; CHAO-CHI HO; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2020-12-02T02:34:20Z |
Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer
|
Wu J.-Y.;Shih J.-Y.;Yang C.-H.;Chen K.-Y.;Ho C.-C.;Yu C.-J.;Pan-Chyr Yang; Wu J.-Y.; Shih J.-Y.; Yang C.-H.; Chen K.-Y.; Ho C.-C.; Yu C.-J.; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-04-29T05:09:15Z |
Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer
|
Wu J.-Y.; Shih J.-Y.; Yang C.-H.; KUAN-YU CHEN; Ho C.-C.; Yu C.-J.; Yang P.-C. |
| 臺大學術典藏 |
2021-04-29T02:38:42Z |
Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer
|
Anonymous |
| 臺大學術典藏 |
2022-06-27T07:07:47Z |
Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancer
|
Wu J.-Y.; Shih J.-Y.; Yang C.-H.; Chen K.-Y.; Ho C.-C.; CHONG-JEN YU; Yang P.-C. |
